Abstract
As the federal government's role in health policy has grown, its involvement in the development, adoption, and use of medical technology has grown concomitantly. The government now makes a wide variety of decisions concerning technology. Many of these decisions involve randomized clinical trials (RCTs). The federal government probably funds or requires a majority of the RCTs carried out in the United States. The federal government also uses the results of RCTs increasingly as an important basis for its decisions, especially within the Medicare program. As the scientific basis for medical practice has improved through use of the RCT, policy decisions have been put on a firmer base.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
